Literature DB >> 27458813

Glioblastoma Multiforme and Adult Neurogenesis in the Ventricular-Subventricular Zone: A Review.

Claudia Capdevila1, Lucía Rodríguez Vázquez1, Joaquín Martí1.   

Abstract

Brain cancers account for <1,5% of all new cancer cases reported in the United States each year. Due to their invasive and heterogeneous nature, in addition to their resistance to multimodal treatments, these tumors are usually fatal. Gliomas, and in particular high-grade astrocytomas such as glioblastoma multiforme (GBM), are the most common and lethal primary tumors of the central nervous system. The median survival of most patients is less than 1 year after application of multimodal therapies. The question is why are these cancers so injurious? And above all, how is it possible for a so carefully orchestrated area like the brain to develop such tumors? This brings us to the study of glioma stem cells, their specialized niches (perivascular and hypoxic), and the neurogenic phenomena that takes place within the adult ventricular-subventricular zone: a structure that lies at the intersection between brain development and gliomagenesis. J. Cell. Physiol. 232: 1596-1601, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 27458813     DOI: 10.1002/jcp.25502

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymes.

Authors:  Ravi P Cholia; Monisha Dhiman; Raj Kumar; Anil K Mantha
Journal:  Metab Brain Dis       Date:  2018-05-02       Impact factor: 3.584

2.  Does risk of brain cancer increase with intracranial volume? A population-based case control study.

Authors:  Even Hovig Fyllingen; Tor Ivar Hansen; Asgeir Store Jakola; Asta Kristine Håberg; Øyvind Salvesen; Ole Solheim
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

3.  Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.

Authors:  Brent D Weinberg; Lauren Boreta; Steve Braunstein; Soonmee Cha
Journal:  J Neurooncol       Date:  2018-03-15       Impact factor: 4.130

4.  Natural Diterpenoid Isoferritin A (IsoA) Inhibits Glioma Cell Growth and Metastasis via Regulating of TGFβ-Induced EMT Signal Pathway.

Authors:  Bin Shen; Dezhou Sun
Journal:  Med Sci Monit       Date:  2018-06-06

Review 5.  Interactions Between Neural Progenitor Cells and Microglia in the Subventricular Zone: Physiological Implications in the Neurogenic Niche and After Implantation in the Injured Brain.

Authors:  Esperanza R Matarredona; Rocío Talaverón; Angel M Pastor
Journal:  Front Cell Neurosci       Date:  2018-08-20       Impact factor: 5.505

6.  Molecular Pathological Markers Correlated With the Recurrence Patterns of Glioma.

Authors:  Shunnan Ge; Yingwu Shi; Gang Zhu; Songlun Li; Yaning Cai; Peigang Ji; Jinghui Liu; Wei Guo; Li Gong; Miao Lou; Fuqiang Feng; Yuan Wang; Yulong Zhai; Yan Qu; Liang Wang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

7.  β2-Adrenergic receptor agonist enhances the bystander effect of HSV-TK/GCV gene therapy in glioblastoma multiforme via upregulation of connexin 43 expression.

Authors:  Saereh Hosseindoost; Seyed Mojtaba Mousavi; Ahmad Reza Dehpour; Seyed Amirhossein Javadi; Babak Arjmand; Ali Fallah; Mahmoudreza Hadjighassem
Journal:  Mol Ther Oncolytics       Date:  2022-06-06       Impact factor: 6.311

Review 8.  Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma.

Authors:  Funto A Akindona; Stephen C Frederico; John C Hancock; Mark R Gilbert
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

Review 9.  Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential.

Authors:  Marina Digregorio; Arnaud Lombard; Paul Noel Lumapat; Félix Scholtes; Bernard Rogister; Natacha Coppieters
Journal:  Cells       Date:  2019-11-29       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.